Literature DB >> 21974813

Insulin secretion, nutritional status and respiratory function in cystic fibrosis patients with normal glucose tolerance.

Gianfranco Alicandro1, Pier Maria Battezzati, Alberto Battezzati, Chiara Speziali, Laura Claut, Valentina Motta, Silvana Loi, Carla Colombo.   

Abstract

BACKGROUND & AIMS: Impaired growth and nutritional status in CF may be related to progressive insulin deficiency before CF-Related Diabetes has established. Aim of this study was to analyse the association of circulating insulin with nutritional status and lung function in CF patients with normal glucose tolerance (NGT).
METHODS: We performed OGTT in 152 consecutive CF patients aged 8-20 years: 115 of them had NGT and were included in the study. Areas under the curves (AUC) of glucose, insulin and c-peptide after 120 min were calculated. Quartiles (Q) of increasing fasting insulin (fINS-Q) and c-peptide (fCP-Q) levels were calculated in CF patients. Respiratory function parameters (FEV1, FVC), Standard Deviation Scores (SDS) of height, weight and BMI were compared between Q1 and the three higher Q. Multiple regression analysis was used to analyse the association of fasting insulin, c-peptide or OGTT derived indices with nutritional or respiratory parameters.
RESULTS: Compared to patients in fINS-Q4 or fCP-Q4, those in fINS-Q1 or in fCP-Q1 respectively showed lower levels of insulin AUC or c-peptide AUC (both P < 0.0001), weight-SDS (P = 0.013, P = 0.007), BMI-SDS (P = 0.010, P = 0.002), FEV1 (P = 0.076, P = 0.013) and FVC (P = 0.101, P = 0.009). Age- and gender-adjusted regression analysis showed significant associations of fINS and fCP with SDS of BMI (P = 0.023 and P = 0.001 respectively), fCP was significant associated with FEV1 (P = 0.01). AUC insulin/AUC glucose ratio (P < 0.0001) and AUC c-peptide/AUC glucose ratio (P = 0.0001) were significantly associated with FEV1.
CONCLUSIONS: Insulin deficiency in CF patients with NGT has a significant impact on clinical outcomes.
Copyright © 2011 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21974813     DOI: 10.1016/j.clnu.2011.09.007

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  5 in total

1.  Abnormal Glucose Tolerance in Infants and Young Children with Cystic Fibrosis.

Authors:  Yaling Yi; Andrew W Norris; Kai Wang; Xingshen Sun; Aliye Uc; Antoinette Moran; John F Engelhardt; Katie Larson Ode
Journal:  Am J Respir Crit Care Med       Date:  2016-10-15       Impact factor: 21.405

Review 2.  Cystic fibrosis related diabetes.

Authors:  Donal O'Shea; Jean O'Connell
Journal:  Curr Diab Rep       Date:  2014-08       Impact factor: 4.810

Review 3.  Cystic Fibrosis-Related Diabetes.

Authors:  Kayani Kayani; Raihan Mohammed; Hasan Mohiaddin
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-20       Impact factor: 5.555

4.  Association between Lung Function and New-Onset Diabetes Mellitus in Healthy Individuals after a 6-Year Follow-up.

Authors:  Hwa Young Lee; Juyoung Shin; Hyunah Kim; Seung-Hwan Lee; Jae-Hyoung Cho; Sook Young Lee; Hun-Sung Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2021-12-13

5.  Prepuberal insulin secretory indices are long-term predictors of short adult stature in cystic fibrosis.

Authors:  Alberto Battezzati; Andrea Foppiani; Gianfranco Alicandro; Arianna Bisogno; Arianna Biffi; Giorgio Bedogni; Simona Bertoli; Giulia De Carlo; Erica Nazzari; Carla Colombo
Journal:  Endocr Connect       Date:  2022-05-10       Impact factor: 3.221

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.